Search Results

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

• Authors : MacArthur, Rodger D¹ ; Novak, Richard M²; Peng, Grace³

• Source: Lancet. 12/16/2006, Vol. 368 Issue 9553, p2125-2135. 11p. 4 Charts, 7 Graphs.

Record details

Role of parametric resonance in virological failure during HIV treatment interruption therapy.

• Authors : Breban, Romulus¹; Blower, Sally¹

• Source: Lancet. 4/15/2006, Vol. 367 Issue 9518, p1285-1289. 5p. 1 Chart, 2 Graphs.

Record details

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

• Authors : Mallal, S; Nolan, D; Witt, C

• Source: Lancet. 3/2/2002, Vol. 359 Issue 9308, p727-732. 6p. 2 Diagrams, 3 Charts.

Record details

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.

• Authors : Benhamou, Y; Bochet, M; Thibault, V

• Source: Lancet. 9/1/2001, Vol. 358 Issue 9283, p718-723. 6p. 2 Graphs.

Record details

Effect of recent thymic emigrants on progression of HIV-1 disease.

• Authors : Hatzakis, Angelos; Touloumi, Giota; Karanicolas, Rose

• Source: Lancet. 2/19/2000, Vol. 355 Issue 9204, p599-604. 6p. 1 Chart, 5 Graphs.

Record details

Paediatric HIV-1 infection.

• Authors : Burns, David N.; Mofenson, Lynne M.

• Source: Lancet. Sep1999 Supplement Paediatrics, Vol. 354 Issue 9180, psII1. 6p. 1 Chart, 1 Graph.

Record details

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

• Authors : Mocroft, A.; Vella, S.; Benfield, T.L.

• Source: Lancet. 11/28/1998, Vol. 352 Issue 9142, p1725-1730. 6p. 4 Charts, 2 Graphs.

Record details

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.

• Authors : Foudraine, Norbert A.; Hoetelmans, Richard M.W.; Lange, Joep M.A.

• Source: Lancet. 5/23/1998, Vol. 351 Issue 9115, p1547. 5p. 2 Charts, 6 Graphs.

Record details

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.

• Authors : Halsey, Neal A.; Coberly, Jacqueline S.; Desormeaux, Julio

• Source: Lancet. 3/14/1998, Vol. 351 Issue 9105, p786. 7p. 1 Diagram, 5 Charts, 3 Graphs.

Record details

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regi

• Source: Lancet. 5/17/1997, Vol. 349 Issue 9063, p1413. 9p. 1 Diagram, 4 Charts, 3 Graphs.

Record details